Modular Medical, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- James E. Besser
- Full Time Employees
- 51
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 10740 Thornmint Road San Diego CA United States of America 92127
- IPO Date
- Feb 10, 2022
- CIK
- 0001074871
- Website
- modularmedical.com
- Similar Companies
- Business
- Modular Medical, Inc. (NASDAQ:MODD) develops and commercializes innovative insulin delivery systems for diabetes management, targeting type 1 and type 2 patients transitioning from multiple daily injections with simplified, affordable patch pump technology. The company offers MODD1, a two-part disposable patch pump featuring micro-pumping mechanics, user-friendly interfaces, data sharing capabilities for healthcare providers, and proprietary electronic controls; it also advances Pivot, a next-generation tubeless insulin pump undergoing clinical feasibility studies, Institutional Review Board-approved testing with sterile saline simulations, and preparations for FDA submission in October 2025 alongside CE mark pursuits for international markets. Founded in 1998 by Paul DiPerna, who previously led Tandem Diabetes Care, Modular Medical maintains headquarters at 10740 Thornmint Road, San Diego, California, operates from Nevada incorporation, employs 54 staff, and partners with Phillips-Medisize for scalable manufacturing while holding multiple U.S. and foreign patents on its technologies. Recent developments include a $12 million private placement in March 2025 to enhance MODD1 supply chain and margins while funding Pivot development; $1.3 million in insider purchases by CEO James Besser and affiliates at $1.92 per share; a $4.4 million warrant exercise in September 2025 yielding new five-year warrants at $0.84 exercise price; completion of a MODD1 clinical study with nine type 1 clinicians for Pivot refinements; and ongoing efforts toward mass-market adoption in the $3 billion diabetes device sector.
Company News
Modular Medical Secures National PBM Contract For Pivot Insulin Pump
Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump
Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements
EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades
Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026
Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference
Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026
Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman
Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records
Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery
Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion
Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump